Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 701-711

  Teow, Huey Minn ^a   Zhou, Zhengyuan ^a   Najlah, Mohammad ^b   Yusof, Siti R ^c,d   Abbott, N Joan ^c   D'Emanuele, Antony ^a  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b Albaath University   (Syrian Arab Republic)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Blood brain barrier; Caco 2 cells; Drug delivery; Nano carrier; Paclitaxel, Dendrimer prodrugs

Indexed keywords

DENDRIMER; FLUORESCEIN ISOTHIOCYANATE; GLUTARIC ACID DERIVATIVE; GLUTARIC ANHYDRIDE; LAURIC ACID; MULTIDRUG RESISTANCE PROTEIN; NANOCARRIER; PACLITAXEL; POLYAMIDOAMINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; BRAIN ENDOTHELIAL CELL; CANCER CELL CULTURE; CELL STRUCTURE; CELL TYPE; CHEMICAL MODIFICATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STABILITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LABELING INDEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CACO-2 CELLS; COLONIC NEOPLASMS; DENDRIMERS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; HUMANS; NANOPARTICLES; PACLITAXEL; PERMEABILITY; SWINE;

EID: 84872799173     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.10.024     Document Type: Article

References (65)

1. N.J. Abbott, D.E.M. Dolman, and A.K. Patabendige Assays to predict drug permeation across the blood-brain barrier, and distribution to brain Curr. Drug Metab. 9 2008 901 910
2. N.J. Abbott, A.K. Patabendige, D.E.M. Dolman, S.R. Yusof, and D.J. Begley Structure and function of the blood-brain barrier Neurobiol. Dis. 37 2010 13 25
3. N.J. Abbott, and I.A. Romero Transporting therapeutics across the blood-brain barrier Mol. Med. Today 2 1996 106 113
4. P. Artursson Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
5. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
6. C. Ballatore, B. Zhang, J.Q. Trojanowski, V.M.Y. Lee, and A.B. Smith III In situ blood-brain barrier permeability of a C-10 paclitaxel carbamate Bioorg. Med. Chem. Lett. 18 2008 6119 6121
7. E.V. Batrakova, S.V. Vinogradov, S.M. Robinson, M.L. Niehoff, W.A. Banks, and A.V. Kabanov Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery Bioconjug. Chem. 16 2005 793 802
8. D.J. Begley Delivery of therapeutic agents to the central nervous system: the problems and the possibilities Pharmacol. Ther. 104 2004 29 45
9. X. Bi, X. Shi, I.J. Majoros, R. Shukla, and J.R. Baker Multifunctional poly(amidoamine) dendrimer-taxol conjugates: synthesis, characterization and stability J. Comput. Theor. Nanosci. 4 2007 1179 1187
10. A. D'Emanuele, and D. Attwood Dendrimer-drug interactions Adv. Drug Deliv. Rev. 57 2005 2147 2162
11. A. D'Emanuele, D. Attwood, and R. Abu-Rmaileh Dendrimers J. Swarbrick, Encyclopaedia of Pharmaceutical Technology third ed. 2006 Informa Healthcare USA 872 890
12. A. D'Emanuele, R. Jevprasesphant, J. Penny, and D. Attwood The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability J. Control. Release 95 2004 447 453
13. H.M. Deutsch, J.A. Glinski, M. Hernandez, R.D. Haugwitz, V.L. Narayanan, M. Suffness, and L.H. Zalkow Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity J. Med. Chem. 32 1989 788 792
14. B. Devarakonda, A. Judefeind, S. Chigurupati, S. Thomas, G.V. Shah, D.P. Otto, and M.M. de Villiers The effect of polyamidoamine dendrimers on thein vitro cytotoxicity of paclitaxel in cultured prostate cancer (PC-3M) cells J. Biomed. Nanotechnol. 3 2007 384 393
15. F. Dosio, P. Brusa, P. Crosasso, S. Arpicco, and L. Cattel Preparation, characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugate J. Control. Release 47 1997 293 304
16. M. El-Sayed, M. Ginski, C.A. Rhodes, and H. Ghandehari Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers J. Control. Release 81 2002 355 365
17. M. El-Sayed, C.A. Rhodes, M. Ginski, and H. Ghandehari Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers Int. J. Pharm. 265 2003 151 157
18. C. Engelbertz, D. Korte, T. Nitz, H. Franke, M. Haselbach, J. Wegener, and H.-J. Galla The development of in vitro models for the blood-brain and blood-CSF barriers D.J. Begley, M.W. Bradbury, J. Kreuter, The Blood-Brain Barrier and Drug Delivery to the CNS 2000 Marcel Dekker Inc. New York, Basel 33 64
19. S. Fellner, B. Bauer, D.S. Miller, M. Schaffrik, M. Fankhanel, T. Spruss, G. Bernhardt, C. Graeff, L. Farber, H. Gschaidmeier, A. Buschauer, and G. Fricker Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo J. Clin. Invest. 110 2002 1309 1318
20. H. Franke, H.J. Galla, and C.T. Beuckmann Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro Brain Res. Protoc. 5 2000 248 256
21. P.J. Gaillard, and A.G. de Boer Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug Eur. J. Pharm. Sci. 12 2000 95 102
22. P.J. Gaillard, L.H. Voorwinden, J.L. Nielsen, A. Ivanov, R. Atsumi, H. Engman, C. Ringbom, A.G. de Boer, and D.D. Breimer Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes Eur. J. Pharm. Sci. 12 2001 215 222
23. P. Garberg, M. Ball, N. Borg, R. Cecchelli, L. Fenart, R.D. Hurst, T. Lindmark, A. Mabondzo, J.E. Nilsson, T.J. Raub, D. Stanimirovic, T. Terasaki, J.O. Öberg, and T. Österberg In vitro models for the blood-brain barrier Toxicol. In Vitro 19 2005 299 334
24. D. Goldberg, H. Ghandehari, and P. Swaan Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia Pharm. Res. 27 2010 1547 1557
25. V. Guillemard, and H.U. Saragovi Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity Cancer Res. 61 2001 694 699
26. R. Huang, W. Ke, Y. Liu, C. Jiang, and Y. Pei The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain Biomaterials 29 2008 238 246
27. R. Huang, Y. Qu, W. Ke, J. Zhu, Y. Pei, and C. Jiang Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer FASEB J. 21 2007 1117 1125
28. R. Jevprasesphant, J. Penny, D. Attwood, N.B. McKeown, and A. D'Emanuele Engineering of dendrimer surfaces to enhance transepithelial transport and reduce cytotoxicity Pharm. Res. 20 2003 1543 1550
29. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N.B. McKeown, and A. D'Emanuele The influence of surface modification on the cytotoxicity of PAMAM dendrimers Int. J. Pharm. 252 2003 263 266
30. E.M. Kemper, A.E. van Zandbergen, C. Cleypool, H.A. Mos, W. Boogerd, J.H. Beijnen, and O. van Tellingen Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein Clin. Cancer Res. 9 2003 2849 2855
31. J.J. Khandare, S. Jayant, A. Singh, P. Chandna, Y. Wang, N. Vorsa, and T. Minko Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel Bioconjug. Chem. 17 2006 1464 1472
32. K.M. Kitchens, M.E.H. El-Sayed, and H. Ghandehari Transepithelial and endothelial transport of poly (amidoamine) dendrimers Adv. Drug Deliv. Rev. 57 2005 2163 2176
33. K.M. Kitchens, A. Foraker, R. Kolhatkar, P. Swaan, and H. Ghandehari Endocytosis and interaction of poly (amidoamine) dendrimers with caco-2 cells Pharm. Res. 24 2007 2138 2145
34. R.K. Locke, V.B. Bastone, and R.L. Baron Studies of carbamate pesticide metabolism utilizing plant and mammalian cells in culture J. Agric. Food Chem. 19 1971 1205 1209
35. N.F. Magri, and D.G.I. Kingston Modified taxols. 2. Oxidation products of taxol J. Org. Chem. 51 1986 797 802
36. I.J. Majoros, A. Myc, T. Thomas, C.B. Mehta, and J.R. Baker PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 7 2006 572 579
37. I.J. Majoros, T.P. Thomas, C.B. Mehta, and J.R. Baker Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy J. Med. Chem. 48 2005 5892 5899
38. W. Mellado, N.F. Magri, D.G.I. Kingston, R. Garcia-Arenas, G.A. Orr, and S.B. Horwitz Preparation and biological activity of taxol acetates Biochem. Biophys. Res. Commun. 124 1984 329 336
39. M. Najlah, and A. D'Emanuele Crossing cellular barriers using dendrimer nanotechnologies Curr. Opin. Pharmacol. 6 2006 522 527
40. M. Najlah, S. Freeman, D. Attwood, and A. D'Emanuele Synthesis, characterization and stability of dendrimer prodrugs Int. J. Pharm. 308 2006 175 182
41. M. Najlah, S. Freeman, D. Attwood, and A. D'Emanuele Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates Bioconjug. Chem. 18 2007 937 946
42. M. Najlah, S. Freeman, D. Attwood, and A. D'Emanuele In vitro evaluation of dendrimer prodrugs for oral drug delivery Int. J. Pharm. 336 2007 183 190
43. H. Ogura, S. Nagai, and K. Takeda A novel reagent (N-succinimidyl diphenylphosphate) for synthesis of active ester and peptide Tetrahedron Lett. 21 1980 1467 1468
44. I. Ojima, O. Duclos, G. Dorman, B. Simonot, G.D. Prestwich, S. Rao, K.A. Lerro, and S.B. Horwitz A new paclitaxel photoaffinity analog with a 3-(4-benzoylphenyl)propanoyl probe for characterization of drug-binding sites on tubulin and P-glycoprotein J. Med. Chem. 38 1995 3891 3894
45. T. Ooya, J. Lee, and K. Park Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel J. Control. Release 93 2003 121 127
46. T. Ooya, J. Lee, and K. Park Hydrotropic dendrimers of generations 4 and 5: synthesis, characterization, and hydrotropic solubilization of paclitaxel Bioconjug. Chem. 15 2004 1221 1229
47. Patabendige, A., Skinner, R.A., Abbott, N.J., 2012. Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res., July 10 (Epub ahead of print).
48. N. Perrière, P.H. Demeuse, E. Garcia, A. Regina, M. Debray, J.P. Andreux, P. Couvreur, J.M. Scherrmann, J. Temsamani, P.O. Couraud, M.A. Deli, and F. Roux Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties J. Neurochem. 93 2005 279 289
49. A. Rice, Y. Liu, M.L. Michaelis, R.H. Himes, G.I. Georg, and K.L. Audus Chemical modification of paclitaxel (Taxol) reduces P-glycoprotein interactions and increases permeation across the blood-brain barrier in vitro and in situ J. Med. Chem. 48 2005 832 838
50. E.K. Rowinsky, L.A. Cazenave, and R.C. Donehower Taxol: a novel investigational antimicrotubule agent J. Natl. Cancer Inst. 82 1990 1247 1259
51. L.L. Rubin, D.E. Hall, S. Porter, K. Barbu, C. Cannon, H.C. Horner, M. Janatpour, C.W. Liaw, K. Manning, and J. Morales A cell culture model of the blood-brain barrier J. Cell Biol. 115 1991 1725 1735
52. A. Safavy, G.I. Georg, D.V. Velde, K.P. Raisch, K. Safavy, M. Carpenter, W. Wang, J.A. Bonner, M.B. Khazaeli, and D.J. Buchsbaum Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure Bioconjug. Chem. 15 2004 1264 1274
53. A. Saovapakhiran, A. D'Emanuele, D. Attwood, and J. Penny Surface modification of PAMAM dendrimers modulates the mechanism of cellular internalization Bioconjug. Chem. 20 2009 693 701
54. Y. Shao, H. Ding, W. Tang, L. Lou, and L. Hu Synthesis and structure-activity relationships study of novel anti-tumor carbamate anhydrovinblastine analogues Bioorg. Med. Chem. 15 2007 5061 5075
55. Q. Shi, H.-K. Wang, K.F. Bastow, Y. Tachibana, K. Chen, F.-Y. Lee, and K.-H. Lee Antitumor agents 210. Synthesis and evaluation of taxoid- epipodophyllotoxin conjugates as novel cytotoxic agents Bioorg. Med. Chem. 9 2001 2999 3004
56. R.A. Skinner, R.M. Gibson, N.J. Rothwell, E. Pinteaux, and J.I. Penny Transport of interleukin-1 across cerebromicrovascular endothelial cells Br. J. Pharmacol. 156 2009 1115 1123
57. F. Thomas, K. Taskar, V. Rudraraju, S. Goda, H. Thorsheim, J. Gaasch, R. Mittapalli, D. Palmieri, P. Steeg, P. Lockman, and Q. Smith Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer Pharm. Res. 26 2009 2486 2494
58. D.A. Tomalia, H. Baker, J. Dewald, M. Hall, G. Kallos, S. Martin, J. Roeck, J. Ryder, and P. Smith A new class of polymers: starburst-dendritic macromolecules Polym. J. 7 1985 117 132
59. D.A. Tomalia, A.M. Naylor, and W.A.I. Goddard Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter Angew. Chem. Int. Ed. 29 1990 138 175
60. M. Török, J. Huwyler, H. Gutmann, G. Fricker, and J. Drewe Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions Exp. Brain Res. 153 2003 356 365
61. B.J. Turunen, H. Ge, J. Oyetunji, K.E. Desino, V. Vasandani, S. Güthe, R.H. Himes, K.L. Audus, A. Seelig, and G.I. Georg Paclitaxel succinate analogs: anionic and amide introduction as a strategy to impart blood-brain barrier permeability Bioorg. Med. Chem. Lett. 18 2008 5971 5974
62. I.C.J. van der Sandt, P.J. Gaillard, H.H. Voorwinden, A.G. de Boer, and D.D. Breimer P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier Pharm. Res. 18 2001 587 592
63. K.A. Youdim, A. Avdeef, and N.J. Abbott In vitro trans-monolayer permeability calculations: often forgotten assumptions Drug Discov. Today 8 2003 997 1003
64. T.Y. Zakharian, A. Seryshev, B. Sitharaman, B.E. Gilbert, V. Knight, and L.J. Wilson A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture J. Am. Chem. Soc. 127 2005 12508 12509
65. Y. Zhang, C.S.W. Li, Y. Ye, K. Johnson, J. Poe, S. Johnson, W. Bobrowski, R. Garrido, and C. Madhu Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability Drug Metab. Dispos. 34 2006 1935 1943